Figure 4. SCO2 overexpression in TP53 mutation background.
(A) Bar graph showing average SCO2 expression levels in tumors loss or gain in copy number compared to somatic levels in the pan-cancer dataset. (B) Bar graph showing average expression of SCO2 in context of p53 mutation background. P-values in (A,B) indicate significance level from one-way ANOVA. (C) Kaplan-Meier survival curves indicating the influence of tumor stratification on the basis of low (n = 4366) or high (n = 3025) SCO2 expression in the pan-cancer dataset. (D) Kaplan-Meier survival curves showing the influence of wild-type p53 and low SCO2 expression (n = 1561), wild-type p53 with high SCO2 expression or mutant p53 with low SCO2 expression (n = 1269), and mutant p53 with high SCO2 expression (n = 495) on the survival rates in the pan-cancer dataset. P-values in (C,D) indicate significance levels from the comparison of survival curves using the Log-rank (Mantel-Cox) test.
